Additionally, CYP is also involved in the activation and/or inactivation of anticancer agents, which indicates that the expression of CYP in lung cancer and paraneoplastic tissues may be an important factor in the efficacy of anticancer drugs. The gene discussed is PPIG; the disease is lung carcinoma.